The 20th edition of BioAsia – The Marquee Healthcare and Life Sciences event, organized by the Government of Telangana, has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof. Robert S. Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases. Langer is currently the David H. Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin, and vaccines.
Related Posts
IDM launched Micro Credential Workshops for Design Course Aspirants
India 13th November,2025:– The Institute of Design & Media, a leading design institute in India, has launched micro-credential workshops, each…
Lexar gears up to tap into India’s multi-billion dollar content creation industry
7th July 2023: Lexar, a leading global provider of memory and storage solutions, is set to expand its distribution channel…
Quadrasystems.net Among the First in India to Achieve ISO/IEC 42001:2023, the World’s First International Standard for AI Management Systems
Certification, audited by TÜV SÜD, places the Coimbatore-headquartered firm’s AI practice in an elite group of organisations worldwide to meet…